Name
osaühing BIOMED
Registry code
10003494
VAT number
EE100631104
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.11.1995 (29)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
72111 - Research and experimental development on biotechnology
9 403 €
-9 739 €
-104%
-
16 782 €
0
Submitted
No tax arrears
-58%
-41%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Rein Kolk 12.09.1961 (63) | 50% - 20 000.00 EEK | Board member | Direct ownership | Founder |
| rain paju 27.01.1960 (64) | 50% - 20 000.00 EEK | - | Direct ownership |
| 2019 03.04.2020 | 2020 05.03.2021 | 2021 11.03.2022 | 2022 14.04.2023 | 2023 12.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 48 747 € | 52 593 € | 4 140 € | 2 151 € | 9 403 € |
| Net profit (loss) for the period | 23 030 € | 30 805 € | -14 242 € | -15 081 € | -9 739 € |
| Profit Margin | 47% | 59% | -344% | -701% | -104% |
| Current Assets | 39 557 € | 46 044 € | 33 462 € | 18 393 € | 15 443 € |
| Fixed Assets | 9 298 € | 36 273 € | 26 716 € | 17 477 € | 8 239 € |
| Total Assets | 48 855 € | 82 317 € | 60 178 € | 35 870 € | 23 682 € |
| Current Liabilities | 4 180 € | 6 071 € | 9 430 € | 9 349 € | 6 900 € |
| Non Current Liabilities | - | 20 402 € | 9 146 € | 0 € | - |
| Total Liabilities | - | 26 473 € | 18 576 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 44 675 € | 55 844 € | 41 602 € | 26 521 € | 16 782 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 440 € | 434.97 € | 266.82 € | - |
| 2023 Q4 | 937 € | 428.52 € | 266.82 € | - |
| 2023 Q3 | 4 077.6 € | 428.52 € | 266.82 € | - |
| 2023 Q2 | 2 948 € | 428.52 € | 266.82 € | - |
| 2023 Q1 | - | 428.52 € | 266.82 € | - |
| 2022 Q4 | 1 569.1 € | 428.52 € | 266.82 € | - |
| 2022 Q3 | 586.3 € | 428.52 € | 266.82 € | - |
| 2022 Q2 | - | 428.52 € | 266.82 € | - |
| 2022 Q1 | 4 140 € | 1 231.02 € | 266.82 € | - |
| 2021 Q4 | - | 428.52 € | 266.82 € | - |
| 2021 Q3 | - | 428.52 € | 266.82 € | - |
| 2021 Q2 | - | 428.52 € | 266.82 € | - |
| 2021 Q1 | - | 428.52 € | 266.82 € | - |
| 2020 Q4 | 11 824 € | 1 082.93 € | 285.49 € | - |
| 2020 Q3 | 4 096.08 € | 4 410.63 € | 1 472.18 € | - |
| 2020 Q2 | 1 391.89 € | - | 266.82 € | - |
| 2020 Q1 | 21 933.17 € | 4 367.76 € | 282.18 € | - |
